$0.6790
-0.0509-6.97%
Calidi Biotherapeutics Inc
CLDIAMEX
The average analyst price target for Calidi Biotherapeutics is $3,200. Of 3 analysts, 3 rate it Buy. Targets range from $1,920 to $3,840. The latest change came on Jun 27, 2024, when Ladenburg Thalmann initiated coverage of Calidi Biotherapeutics with a Buy rating and a $1,920 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
